Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

GCTK

GlucoTrack Inc

Jun 12 • 04:00PM ET

2.55

Dollar change -0.03
Percentage change -1.16	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.92	Insider Own	31.71%	Shs Outstand	4.18M	Perf Week	12.56%
Market Cap	13.97M	Forward P/E	-	EPS next Y	-	Insider Trans	11.74%	Shs Float	3.74M	Perf Month	-5.71%
Income	-8.74M	PEG	-	EPS next Q	-	Inst Own	2.86%	Short Float	0.44%	Perf Quarter	59.67%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.40	Perf Half Y	118.60%
Book/sh	0.08	P/B	30.06	EPS next Y	-	ROA	-509.50%	Short Interest	0.02M	Perf Year	22.89%
Cash/sh	0.27	P/C	9.32	EPS next 5Y	-	ROE	-3799.13%	52W Range	0.66 - 4.95	Perf YTD	95.03%
Dividend Est.	-	P/FCF	-	EPS past 5Y	63.80%	ROI	-1244.73%	52W High	-48.48%	Beta	0.08
Dividend TTM	-	Quick Ratio	1.31	Sales past 5Y	55.66%	Gross Margin	-	52W Low	284.04%	ATR (14)	0.37
Dividend Ex-Date	-	Current Ratio	1.31	EPS Y/Y TTM	-28.52%	Oper. Margin	0.00%	RSI (14)	52.07	Volatility	17.20% 14.46%
Employees	6	Debt/Eq	0.60	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / No	LT Debt/Eq	0.56	EPS Q/Q	-41.37%	Payout	-	Rel Volume	0.38	Prev Close	2.58
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	41.11K	Price	2.55
SMA20	8.43%	SMA50	-1.44%	SMA200	62.50%	Trades		Volume	15,433	Change	-1.16%

Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) -7.19%
Jun-10-24 10:50AM	GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE (GlobeNewswire)
Jun-05-24 08:30AM	GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
May-17-24 02:52PM	GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 (InvestorPlace)
May-16-24 08:30AM	GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY (GlobeNewswire)
04:15PM	Loading…
May-15-24 04:15PM	GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT (GlobeNewswire) -10.20%
May-02-24 09:00AM	GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION (GlobeNewswire)
Apr-29-24 07:33AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +23.00%
Apr-25-24 02:18AM	Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK) (GuruFocus.com)
Apr-22-24 02:10PM	GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT (GlobeNewswire) +9.88%
Apr-16-24 08:30AM	GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING (GlobeNewswire) +24.93%
Apr-03-24 07:00AM	Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire) +13.33%
Apr-02-24 08:30AM	GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +7.46%
07:00AM	Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
Mar-12-24 09:30AM	GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY (GlobeNewswire)
08:30AM	Loading…
Feb-27-24 08:30AM	GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +13.78%
Feb-13-24 09:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAV TO CHAIR OF THE BOARD OF DIRECTORS (GlobeNewswire) -10.79%
Feb-07-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now (GlobeNewswire) +6.28%
Feb-06-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now (GlobeNewswire)
Jan-10-24 07:00AM	Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream (GlobeNewswire)
Jan-09-24 07:00AM	Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now (GlobeNewswire)
Jan-02-24 12:33PM	GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) +8.95%
Nov-30-23 05:39PM	GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT (GlobeNewswire) +7.31%
Nov-13-23 09:00AM	GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE (GlobeNewswire)
Oct-12-23 08:30AM	GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) -20.65%
Aug-31-23 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS (GlobeNewswire)
Aug-28-23 09:00AM	GLUCOTRACK ANNOUNCES NEW VP OF MARKETING (GlobeNewswire)
Jul-26-23 02:30PM	The Power Play by The Market Herald Releases New Interviews with GlucoTrack and Acceleware Discussing Their Latest News (ACCESSWIRE) -7.95%
Jul-25-23 09:00AM	GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire)
Apr-17-23 11:05AM	Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK) (ACCESSWIRE) -7.39%
09:15AM	Loading…
09:15AM	GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Apr-13-23 09:22AM	GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -49.26%
Apr-12-23 05:50PM	GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock (GlobeNewswire) +37.76%
Mar-14-23 10:00AM	GLUCOTRACK PROVIDES SHAREHOLDER UPDATE (GlobeNewswire) +16.94%

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SYCOFF DREW	Director	Apr 22 '24	Buy	1.26	182,540	230,000	2,951,258	Apr 24 06:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GCTK

GlucoTrack Inc

Upgrade your FINVIZ experience